ARCAGY- GYNECO   Report issue

Foundation Phase 2
Founded: Paris France (1993)

Organization Overview

First Clinical Trial
2019
NCT04053322
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

ARCAGY- GYNECO

Active Ingredients

Drugs in Phase 2 Trials (3)

durvalumab (imfinzi) (1 trial)

fulvestrant (faslodex) (1 trial)

olaparib (lynparza) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 3